INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial (ACDF)
A Pivotal Clinical Investigation of INFUSE® Bone Graft With a PEEK Interbody Spacer and an Anterior Cervical Plate in Patients With Cervical Degenerative Disc Disease at a Single Level.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Beverly Hills, California, United States, 90210
- S & B Surgery Center
-
Laguna Hills, California, United States, 92653
- Orange County Neurological Association
-
-
Florida
-
Melbourne, Florida, United States, 32901
- Crane Creek Medical Ctr. The Back Center /Osler Medical
-
-
Georgia
-
Columbus, Georgia, United States, 31908
- The Hughston Clinic, P.C.
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Medcal Center
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71103
- Spine Institute
-
-
Missouri
-
Springfield, Missouri, United States, 65804
- Springfield Neurological Institute
-
-
New York
-
West Seneca, New York, United States, 14224
- Buffalo Neurosurgery Group
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- University of Cincinnati Dept of Neurosurgery
-
Norwood, Ohio, United States, 45212
- TriState Orthopedic Treatment Center
-
-
Pennsylvania
-
Washington, Pennsylvania, United States, 15301
- The Washington Hospital
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Center for Sports Medcine & Orthopedics
-
Memphis, Tennessee, United States, 38120
- Semmes Murphey Neurologic & Spine Institute
-
-
Texas
-
Austin, Texas, United States, 78731
- Central Texas Spine
-
Plano, Texas, United States, 75093
- Brain and Spine Center of Texas, L.L.P.
-
-
Washington
-
Spokane, Washington, United States, 99204
- Inland Neurosurgery & Spine Associates, P.S.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
INCLUSION:
- Single-level cervical degenerative disc disease (from C3-C7) requiring surgical treatment and involving intractable radiculopathy and/or myelopathy.
- Herniated disc and/or osteophyte formation at the level to be treated that is producing symptomatic nerve root and/or spinal cord compression.
- Unresponsive to non-operative treatment for six weeks or has the presence of progressive symptoms or signs of nerve root/spinal cord compression in the face of continued non-operative management.
- At least 18 years of age and skeletally mature at the time of surgery.
- A preoperative Neck Disability Index (NDI) score ≥30.
- A preoperative neck pain score (pain intensity + pain frequency) ≥8 (out of 20) based on the preoperative Neck and Arm Pain Questionnaire.
- If a female of childbearing potential, patient is not pregnant or nursing and agrees not to become pregnant for one year following surgery.
- Is willing and able to comply with the study plan and able to understand and sign the Patient Informed Consent Form.
Exclusion Criteria:
EXCLUSION:
- A cervical spinal condition other than symptomatic cervical degenerative disc disease requiring surgical treatment at the involved level.
- Documented or diagnosed cervical instability at the target level, defined by dynamic (flexion/extension) radiographs.
- Previous surgical intervention at the involved level.
- Any subsequent planned/staged surgical procedure at the involved or adjacent level(s).
- Fused level adjacent to the level to be treated.
- Severe pathology of the facet joints of the involved vertebral bodies.
- Has osteoporosis, osteopenia, or osteomalacia as determined by DEXA scan.
- Presence of active malignancy or prior history of malignancy (except for basal cell carcinoma of the skin).
- Overt or active bacterial infection, either local or systemic.
- Insulin dependent diabetes.
- Chronic or acute renal failure or prior history of renal disease.
- Documented allergy or intolerance to stainless steel, titanium, titanium alloy, polyetheretherketone (PEEK), or tantalum.
- Is mentally incompetent. (if questionable, obtain psychiatric consult.)
- Is a prisoner.
- Is an alcohol and/or drug abuser as defined by currently undergoing treatment for alcohol and/or drug abuse.
- On oral or injectable steroids for 6 weeks or more at the time of enrollment.
- A history of autoimmune disease.
- History of exposure to injectable collagen or silicone implants.
- History of hypersensitivity to protein pharmaceuticals (monoclonal antibodies or gamma globulins) or collagen.
- Received any previous exposure to any/all BMPs either human or animal extraction.
- History of allergy to bovine products.
- History of any allergy resulting in anaphylaxis.
- History of an endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's Disease, renal osteodystrophy, Ehlers-Danlos Syndrome, or osteogenesis imperfecta).
- Condition that requires postoperative medications that interfere with the stability of the implant, such as steroids.
- Received treatment with an investigational therapy (drug, device, or biologic) within 28 days prior to implantation surgery or such treatment is planned during the 24-month period following the study surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: INFUSE® Bone Graft
In this arm, patients will receive implant with INFUSE® Bone Graft/PEEK Spacer/Anterior Cervical Plate.
|
All patients enrolled in this study will receive the investigational device.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Overall Success
Time Frame: 24 months post-operation
|
Rate of overall success is reported as the percentage of participants who met all of the following criteria:
|
24 months post-operation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative Time
Time Frame: Time of operation, approximately 1.5 hrs.
|
Operative time was recorded from skin incision to wound closure.
|
Time of operation, approximately 1.5 hrs.
|
|
Blood Loss
Time Frame: During the time of operation, approximately 1.5 hours.
|
During the time of operation, approximately 1.5 hours.
|
|
|
Hospital Stay
Time Frame: During the time of hospital stay, average of 1 day.
|
During the time of hospital stay, average of 1 day.
|
|
|
Success Rate of Fusion
Time Frame: 24 months post-operation
|
Success Rate of Fusion is reported as percent of participants who met the following fusion criteria:
|
24 months post-operation
|
|
Success Rate of Neck Disability Index
Time Frame: 24 months post-operation
|
Success rate of Neck Disability Index is reported as the percentage of participants whose neck disability index score met: Pre-treatment Score - Post-treatment Score ≥ 15.
|
24 months post-operation
|
|
Success Rate of Neurological Status
Time Frame: 24 months post-operation
|
Success rate of neurological status is reported as the percentage of participants who met neurological success defined as maintenance or improvement in all sections (motor, sensory, and reflexes) for the time period evaluated.
In order for a section to be considered a success, each element in the section must remain the same or improve from the time of the preoperative evaluation to the time period evaluated.
|
24 months post-operation
|
|
Neck Pain Success Rate
Time Frame: 24 months post-operation
|
Neck pain success rate is reported as the percentage of participants whose neck pain improvement met: Preoperative Score - Postoperative Score > 0.
|
24 months post-operation
|
|
Arm Pain Success Rate
Time Frame: 24 months post-operation
|
Arm pain success rate is reported as the percentage of participants whose arm pain improvement met: Preoperative Score - Postoperative Score > 0.
|
24 months post-operation
|
|
Success Rate of SF-36 PCS
Time Frame: 24 months post-operation
|
Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS).
The success rate of SF-36 PCS was defined as: Post Score - Pre Score >= 0.
|
24 months post-operation
|
|
Success Rate of SF-36 MCS
Time Frame: 24 months post-operation
|
Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS).
The success rates of SF-36 MCS were defined as: Post Score - Pre Score >= 0.
|
24 months post-operation
|
|
Number of Patients Who Had Secondary Surgeries at the Index Level
Time Frame: 24 months post-operation
|
Secondary surgical procedures at the index level included revisions, removal, supplemental fixation and reoperations.
|
24 months post-operation
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neck Disability Index Score
Time Frame: 24 months post-operation
|
The self-administered Neck Disability Index (NDI) Questionnaire was used to assess patient neck pain and ability to function.
The NDI scale ranges from 0-100.
The best score is 0 (no disability) and worst is 100 (maximum disability).
|
24 months post-operation
|
|
Neck Pain Score
Time Frame: 24 months post-operation
|
Numerical rating scales are used to evaluate neck pain intensity and frequency.
Patients rate their neck pain intensity on a scale from 0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be."
Similarly, patients record their neck pain frequency on a scale from 0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time."
The total neck pain score is the sum of pain intensity and frequency scores.
|
24 months post-operation
|
|
Arm Pain Score
Time Frame: 24 months post-operation
|
Numerical rating scales are used to evaluate arm pain intensity and frequency.
Patients rate their arm pain intensity on a scale from 0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be."
Similarly, patients record their arm pain frequency on a scale from 0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time."
The total arm pain score will be the sum of pain intensity and frequency scores.
|
24 months post-operation
|
|
General Health Status -- SF-36 PCS
Time Frame: 24 months post-operation
|
The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status.
The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS).
The score for PCS is between 0 and 100, with higher scores denoting better quality of life.
|
24 months post-operation
|
|
General Health Status -- SF-36 MCS
Time Frame: 24 months post-operation
|
The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status.
The SF-36 results are summarized into two components, a physical component summary (PCS) and a mental component summary (MCS).
The score for MCS is between 0 and 100, with higher scores denoting better quality of life.
|
24 months post-operation
|
|
Ossification in the Region of Target Level
Time Frame: 24 months post-operation
|
Ossification in the region of target level is reported as the percentage of the patients who had ossification in the region of the target level.
The region of target level included the index level, the superior and inferior adjacent disc spaces, and the superior and inferior adjacent vertebral bodies.
|
24 months post-operation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- INFUSE® Bone Graft PEEK ACDF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.